Peptide blends explained
Written and maintained by the AVERON Research Desk · Last reviewed September 2026
A peptide blend is a single vial that contains more than one compound. Blends have become common because they reduce the number of separate vials involved. They also work differently from single compounds in ways that matter: how they are made, how they are measured, and how they are tested.
How a blend is made
In a properly made blend, the compounds are combined as a liquid at the factory, in fixed proportions, and then freeze-dried together into one powder. This is called co-lyophilization. The result is a single uniform powder in which every portion contains the compounds in the same ratio.
This is different from someone mixing the contents of separate vials by hand. A factory co-lyophilized blend has a defined composition that can be tested. A hand-mixed vial has whatever composition resulted from that particular mixing, and no laboratory report describes it. AVERON does not mix compounds itself; every blend we carry arrives co-lyophilized from the manufacturer.
Calculating each component's concentration
A blend is reconstituted exactly like a single compound. The difference is that each component has its own concentration, calculated from its own amount:
Component concentration (mg/mL) = that component's mg ÷ total volume (mL)
Worked example: a 70 mg blend in 3 mL
The GLOW blend contains GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg.
| Component | Amount in vial | Concentration in 3 mL | Amount in 0.1 mL |
|---|---|---|---|
| GHK-Cu | 50 mg | 16.67 mg/mL | 1.67 mg |
| BPC-157 | 10 mg | 3.33 mg/mL | 0.33 mg |
| TB-500 | 10 mg | 3.33 mg/mL | 0.33 mg |
| Total | 70 mg | 23.33 mg/mL | 2.33 mg |
Any volume drawn from a blend contains every component, always in the same ratio.
The fixed ratio
The defining feature of a blend is also its main limit: the proportions cannot be changed. Drawing more of one component always means drawing proportionally more of the others. With separate vials, each compound can be measured independently. With a blend, it cannot.
Why blends are tested differently
For a single compound, a laboratory normally reports identity, amount and purity. For a blend, it normally reports the identity and amount of each component, but not a purity figure.
The reason is technical. Purity is measured by HPLC as the share of the total signal that comes from the main compound. In a blend, several main compounds and all of their impurities appear in the same analysis, and their impurity signals overlap. There is no reliable way to say which impurity belongs to which compound, so a purity figure cannot be assigned cleanly. See HPLC purity explained.
That is a limitation of the analysis, not a sign of a poor product. It does mean that a blend's report tells you slightly less than a single compound's report.
Compatibility
Not every combination of compounds is stable together in one vial. Some copper-containing compounds, such as GHK-Cu, can react with other substances. This is one reason blends should come from a manufacturer who formulated them together, and why a blend should have its own dedicated cartridge or container rather than being combined with anything else.
The blends AVERON carries
GLOW, KLOW, Wolverine and the CJC-1295 / Ipamorelin blend. Their compositions and the evidence for each component are on the peptide blends page.
Frequently asked questions
Sources
- Janoshik Analytical. Public test verification portal. Janoshik Analytical. Link